To test whether a
serine elastase inhibitor could prevent or reduce
emphysema, we exposed guinea pigs to cigarette
smoke acutely, or daily for 6 months, and treated some animals with the
neutrophil elastase inhibitor ZD0892. Acute
smoke exposure increased lavage neutrophils and increased
desmosine and
hydroxyproline, measures of
elastin and
collagen breakdown; all these measures were reduced by ZD0892. Long-term
smoke exposure produced
emphysema and increases in lavage neutrophils,
desmosine,
hydroxyproline, and plasma
tumor necrosis factor alpha (
TNF-alpha). ZD0892 treatment returned lavage neutrophils,
desmosine, and
hydroxyproline levels to control values, and decreased airspace enlargement by 45% and
TNF-alpha by 30%. Animals exposed to
smoke for 4 months and then to
smoke plus ZD0892 for 2 months were not protected against
emphysema. Mice exposed to
smoke showed increases in gene expression of neutrophil
chemoattractant macrophage inflammatory protein-2, macrophage
chemoattractant protein-1, and
TNF-alpha at 2 hours along with increased plasma
TNF-alpha; ZD0892 prevented the increases in macrophage inflammatory protein-2 and macrophage
chemoattractant protein-1 expression and reduced plasma
TNF-alpha levels to baseline. These data demonstrate that a
serine elastase inhibitor ameliorates the inflammatory and destructive effects of cigarette
smoke, and that these effects are mediated in part by neutrophils and by
smoke-driven
TNF-alpha production.